{"pmid":32345601,"title":"Covid-19 makes the future of UK clinical research uncertain.","text":["Covid-19 makes the future of UK clinical research uncertain.","BMJ","Iacobucci, Gareth","32345601"],"journal":"BMJ","authors":["Iacobucci, Gareth"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32345601","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/bmj.m1619","locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["General Info"],"weight":1,"_version_":1665441658278248448,"score":8.599203,"similar":[{"pmid":32317247,"title":"What will we learn from covid-19? That we live in an uncertain world.","text":["What will we learn from covid-19? That we live in an uncertain world.","BMJ","Harvey, Judith H","32317247"],"journal":"BMJ","authors":["Harvey, Judith H"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317247","week":"202017|Apr 20 - Apr 26","doi":"10.1136/bmj.m1578","link_comment_for":"32184276","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664815087697788928,"score":80.67033},{"pmid":32241949,"title":"Making allowances for COVID-19.","text":["Making allowances for COVID-19.","Science","Zhou, Ye","32241949"],"journal":"Science","authors":["Zhou, Ye"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241949","week":"202014|Mar 30 - Apr 05","doi":"10.1126/science.368.6486.98","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664638249300131840,"score":67.72455},{"pmid":32331761,"title":"Guidance in an uncertain world.","text":["Guidance in an uncertain world.","Br J Anaesth","Moppett, Iain K","Gardiner, Dale","Harvey, Daniel J R","32331761"],"journal":"Br J Anaesth","authors":["Moppett, Iain K","Gardiner, Dale","Harvey, Daniel J R"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331761","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.bja.2020.04.003","keywords":["covid-19","clinical guidelines","coronavirus","evidence based medicine","guidelines","safety"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1665071049798057984,"score":62.15656},{"pmid":32184129,"pmcid":"PMC7102544","title":"The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19.","text":["The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19.","Our recommendation, as experts who have monitored health hazards at the Hajj for over 15 years, especially if the situation with COVID-19 continues to escalate globally is that Hajj 2020 will be at risk of being suspended and a means for Muslims to fulfill their rights in the future either personally or even by proxy need to be announced. The same holds true for the Summer 2020 Olympics in Japan and for many other MGs and large gatherings. Decisions in the time of COVID-19 will be closely followed and will be a blueprint for other mass gatherings.","Travel Med Infect Dis","Ahmed, Qanta A","Memish, Ziad A","32184129"],"abstract":["Our recommendation, as experts who have monitored health hazards at the Hajj for over 15 years, especially if the situation with COVID-19 continues to escalate globally is that Hajj 2020 will be at risk of being suspended and a means for Muslims to fulfill their rights in the future either personally or even by proxy need to be announced. The same holds true for the Summer 2020 Olympics in Japan and for many other MGs and large gatherings. Decisions in the time of COVID-19 will be closely followed and will be a blueprint for other mass gatherings."],"journal":"Travel Med Infect Dis","authors":["Ahmed, Qanta A","Memish, Ziad A"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32184129","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.tmaid.2020.101631","keywords":["covid-19","hajj","mass gathering","olympics","sars-cov-2","umrah"],"source":"PubMed","topics":["General Info"],"weight":1,"locations":["Muslims","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"_version_":1664640874562191361,"score":57.259937},{"pmid":32238358,"title":"Clinical Research Slows as COVID-19 Surges.","text":["Clinical Research Slows as COVID-19 Surges.","As the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies while keeping immunocompromised patients safe. To that end, cancer centers are making changes to their clinical trial programs, while pharmaceutical companies are deciding how-or whether-trials should continue.","Cancer Discov","32238358"],"abstract":["As the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies while keeping immunocompromised patients safe. To that end, cancer centers are making changes to their clinical trial programs, while pharmaceutical companies are deciding how-or whether-trials should continue."],"journal":"Cancer Discov","date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238358","week":"202014|Mar 30 - Apr 05","doi":"10.1158/2159-8290.CD-NB2020-021","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664638354290900993,"score":56.20886}]}